Vimarsana
Biggest News Aggregation in the World

Cullgen Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cullgen Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cullgen Inc Today - Breaking & Trending Today

Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders - Vimarsana News

Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders

Published: June 15, 2023

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Cullgen Inc. (President and CEO: Ying Luo, Ph.D., "Cullgen")...

Source: prnewswire.com
Related Topics:
Ying LuoAdam PearsonNaoki OkamuraAstellas Pharma IncCullgen IncAstellas PharmaProtein DegradationPrimary FocusesChief Strategy OfficerFocus Area Approach
Cullgen Raises $40M in Financing - Vimarsana News

Cullgen Raises $40M in Financing

Published: May 8, 2023

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Source: finsmes.com
Related Topics:
Ying LuoSan DiegoUnited StatesGroup LtdCullgen IncWuxi Capital GroupVenture Capital PartnershipCapital PartnershipSincere CapitalVoyagers Capital
GNI : summary Q&A from FY2022 AGM | MarketScreener - Vimarsana News

GNI : summary Q&A from FY2022 AGM | MarketScreener

Published: April 11, 2023

This presentation contains statements concerning the current plans, expectations and strategies of GNI... | April 11, 2023

Source: marketscreener.com
Related Topics:
Ying LuoHong KongUnited StatesContinent Pharmaceuticals Co LtdCullgen Shanghai IncHong Kong Stock ExchangeCullgen IncGroup LtdCatalyst Biosciences IncBerkeley Advanced BiomaterialsCullgen ShanghaiProtein DegradationRegarding CullgenBeijing ContinentGni Group Ltd Stock ExchangePress ReleaseF 2160 Jp3386370005